Home Plans About Drugs Register / App Log In Contact
← Back to Drug Database

HLAL RDNA CONSTRUCT IN SBC LAL-C CHICKENS

FDA Application Number: 141-453

Based on the FDA Center for Veterinary Medicine data from August 2019 to May 2025: Of 157 reported animal deaths involving HLAL RDNA CONSTRUCT IN SBC LAL-C CHICKENS, 157 occurred when HLAL RDNA CONSTRUCT IN SBC LAL-C CHICKENS was the only drug administered - representing 100% of all fatalities.

100%
SINGLE-DRUG FATALITIES
HLAL RDNA CONSTRUCT IN SBC LAL-C CHICKENS ONLY
157
TOTAL ANIMALS REPORTED
157
TOTAL FATALITIES
157
SINGLE-DRUG FATALITIES

See more in our app

Top 3 Reported Reactions

Iga Animal Mortality Greater Than Expected
Iga Animal Morbidity Greater Than Expected
Found Dead

See more in our app

SafeVetMeds equips users with the intelligence tools to ask better questions about veterinary drug safety. Powered by 100 million FDA adverse event data points, it delivers advanced safety insights, cross-drug comparisons, and real-world FDA data that is easy to search and simple to understand. The first platform of its kind now available to protect animals.

All data is sourced from the FDA Center for Veterinary Medicine adverse event reports submitted voluntarily by veterinarians, pet owners, and drug manufacturers. This information has not been independently verified and does not establish that any drug caused the reported outcomes. These reports reflect what was submitted to the FDA, not confirmed cause-and-effect relationships or actual risk rates. Reporting rates may vary by drug, manufacturer, and time period, and may be delayed up to 6 months. The percentage shown represents proportions within the reported dataset and does not indicate risk probability or safety ratings. SafeVetMeds is a 501(c)(3) nonprofit providing data transparency infrastructure and does not provide veterinary medical advice, diagnostic services, or legal counsel. For medical decisions regarding your animal, consult a licensed veterinarian. For legal questions, consult an attorney. This data should be considered as one factor among many in medical decision-making, not as definitive evidence of drug safety or danger.